Center-Authored Papers

Filters: Author is Halbert,C. L.  [Clear All Filters]
A
Allen JM, Halbert CL, Miller AD.  2000.  Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.. Molecular therapy : the journal of the American Society of Gene Therapy. 1(1):88-95. Abstract
H
Halbert CL, Alexander IE, Wolgamot GM, Miller AD.  1995.  Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells.. Journal of virology. 69(3):1473-9. Abstract
Halbert CL, Metzger MJ, Lam S-L, Miller AD.  2011.  Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.. Gene therapy. 18(4):411-7. Abstract
Halbert CL, Allen JM, Miller AD.  2001.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.. Journal of virology. 75(14):6615-24. Abstract
Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD.  2000.  Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.. Journal of virology. 74(3):1524-32. Abstract
Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD.  1997.  Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.. Journal of virology. 71(8):5932-41. Abstract
Halbert CL, Aitken ML, Miller AD.  1996.  Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic culture.. Human gene therapy. 7(15):1871-81. Abstract
Halbert CL, Standaert TA, Wilson CB, Miller AD.  1998.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.. Journal of virology. 72(12):9795-805. Abstract
K
Koeberl DD, Bonham L, Halbert CL, Allen JM, Birkebak T, Miller AD.  1999.  Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectors.. Human gene therapy. 10(13):2133-40. Abstract
Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD.  1997.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.. Proceedings of the National Academy of Sciences of the United States of America. 94(4):1426-31. Abstract
Koeberl DD, Halbert CL, Krumm A, Miller AD.  1995.  Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation.. Human gene therapy. 6(4):469-79. Abstract
W
Wang Z, Halbert CL, Lee D, Butts T, Tapscott SJ, Storb R, Miller AD.  2014.  Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.. Gene therapy. 21(4):363-70. Abstract
Weiss DJ, Bonneau L, Allen JM, Miller AD, Halbert CL.  2000.  Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lungs.. Molecular therapy : the journal of the American Society of Gene Therapy. 2(6):624-30. Abstract